Advanced Medicine
Theravance Biopharma, Inc. is a renowned pharmaceutical company dedicated to delivering Medicines that Make a Difference® in the lives of individuals. With a strong focus on innovation and quality, Theravance Biopharma has amassed decades of expertise in the healthcare industry. Their commitment to improving patient outcomes is exemplified by the development of YUPELRI® (revefenacin) inhalation solution, an FDA-approved medication specifically designed for the maintenance treatment of patients suffering from chronic obstructive pulmonary disease (COPD).
At the core of Theravance Biopharma's mission is the pursuit of addressing significant unmet patient needs. Through their pipeline of internally discovered programs, the company aims to revolutionize treatment options for various health conditions. By leveraging cutting-edge research and development, Theravance Biopharma strives to bring forth innovative solutions that have the potential to transform the healthcare landscape and enhance the well-being of individuals worldwide.
With a strong emphasis on efficacy, safety, and patient-centric care, Theravance Biopharma stands as a beacon of excellence in the pharmaceutical realm. Their unwavering dedication to advancing medical science and improving the quality of life for patients underscores their status as a trusted leader in the industry. By fostering a culture of continuous innovation and collaboration, Theravance Biopharma remains committed to making a positive impact on global health and wellness.
